← Back to Analyst Consensus 
EVGN Buy
Evogene Ltd.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 22, 2025 | Lake Street | maintain | Buy → Buy | $3.5 | 47% |
| Aug 23, 2024 | Lake Street | maintain | Buy → Buy | $12 | 47% |
| Oct 2, 2023 | Alliance Global Partners | initiate | — → Buy | $1.85 | 41% |
| Aug 18, 2023 | Lake Street | maintain | Buy → Buy | $3 | 47% |
| Jul 21, 2023 | Roth MKM | maintain | Buy → Buy | $6 | 52% |
| May 2, 2023 | Lake Street | initiate | — → Buy | $2 | 47% |
| Sep 12, 2022 | Aegis Capital | maintain | — → Buy | $8 | — |
| Sep 2, 2022 | Roth MKM | maintain | Buy → Buy | $3 | 52% |
| Oct 8, 2021 | Roth Capital | initiate | — → Buy | $7 | 53% |
| Jul 29, 2021 | Aegis Capital | initiate | — → Buy | $10 | — |
| Dec 1, 2020 | Cantor Fitzgerald | initiate | — → Overweight | $9 | 50% |
Price Target Trend
Apr 6, 2026 Latest: $2.15 Oct 25, 2026
EPS Estimates
0q $-0.19
Lo: $-0.19 Hi: $-0.19
1 analysts ▲1
0y $-1.10
Lo: $-1.10 Hi: $-1.10
1 analysts ▲1
+1y $-0.60
Lo: $-0.60 Hi: $-0.60
1 analysts ▲1
+1q $-0.20
Lo: $-0.20 Hi: $-0.20
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days